SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells
文献类型：期刊论文
| 作者 | Bu, Qiangui ; Cui, Lijing ; Li, Juan ; Du, Xin ; Zou, Waiyi ; Ding, Ke ; Pan, Jingxuan |
| 刊名 | CANCER BIOLOGY & THERAPY
 |
| 出版日期 | 2014 |
| 卷号 | 15期号:7页码:951-962 |
| ISSN号 | 1538-4047 |
| 学科主题 | Oncology |
| 语种 | 英语 |
| 公开日期 | 2016-12-16 |
| 源URL | [http://ir.gibh.ac.cn/handle/344009/321]  |
| 专题 | 广州生物医药与健康研究院_华南干细胞与再生医学研究所_华南干细胞与再生医学研究所_期刊论文 |
| 推荐引用方式 GB/T 7714 | Bu, Qiangui,Cui, Lijing,Li, Juan,et al. SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells[J]. CANCER BIOLOGY & THERAPY,2014,15(7):951-962. |
| APA | Bu, Qiangui.,Cui, Lijing.,Li, Juan.,Du, Xin.,Zou, Waiyi.,...&Pan, Jingxuan.(2014).SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells.CANCER BIOLOGY & THERAPY,15(7),951-962. |
| MLA | Bu, Qiangui,et al."SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells".CANCER BIOLOGY & THERAPY 15.7(2014):951-962. |
入库方式： OAI收割
来源：广州生物医药与健康研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。